Mihaela Tovaru

Mihaela Tovaru


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DMDana Mihaela Mihele
Dana Mihaela Mihele
PNPaul Andrei Nistor
Paul Andrei Nistor
GBGabriela Bruma
Gabriela Bruma
CMCristina Mitran
Cristina Mitran
MMMadalina Irina Mitran
Madalina Irina Mitran
Simona-Roxana GeorgescuSimona-Roxana Georgescu
Simona-Roxana Georgescu
Mast cells (MCs) are infamous for their role in potentially fatal anaphylaxis reactions. In the last two decades, a more complex picture has emerged, as it has become obvious that MCs are much more than just IgE effectors of anaphylaxis. MCs are defenders against a host of infectious and toxic aggressions (their interactions with other components of the immune system are not yet fully understood) and after the insult has ended, MCs continue to play a role in inflammation regulation and tissue repair. Unfortunately, MC involvement in pathology is also significant. Apart from their role in allergies, MCs can proliferate clonally to produce systemic mastocytosis. They have also been implicated in excessive fibrosis, keloid scaring, graft rejection and chronic inflammation, especially at the level of the skin and gut. In recent years, the term MC activation syndrome (MCAS) was proposed to account for symptoms caused by MC activation, and clear diagnostic criteria have been defined. However, not all authors agree with these criteria, as some find them too restrictive, potentially leaving much of the MC-related pathology unaccounted for. Here, we review the current knowledge on the physiological and pathological roles of MCs, with a dermatological emphasis, and discuss the MCAS classification.

27 September 2023 in Viruses
Verified
Journal Article
Open access
PDF file
CCCarmen Elena Condrat
Carmen Elena Condrat
Dragos CretoiuDragos Cretoiu
Dragos Cretoiu
VRViorica Elena Radoi
Viorica Elena Radoi
DMDana Mihaela Mihele
Dana Mihaela Mihele
MTMihaela Tovaru
Mihaela Tovaru
NSNicolae Suciu
Nicolae Suciu
During pregnancy, hormonal and immune adaptations are vital for supporting the genetically distinct fetus during elevated infection risks. The global prevalence of HPV necessitates its consideration during pregnancy. Despite a seemingly mild immune response, historical gestational viral infections underscore its significance. Acknowledging the established HPV infection risks during pregnancy, our review explores the unfolding immunological changes in pregnant women with HPV. Our analysis aims to uncover strategies for safely modulating the immune system, mitigating adverse pregnancy consequences, and enhancing maternal and child health. This comprehensive narrative review delves into the existing knowledge and studies on this topic.